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Edited by Barry HalliwellAbstract We have previously reported that Monad, a novel
WD40 repeat protein, potentiates apoptosis induced by tumor
necrosis factor-a(TNF-a) and cycloheximide (CHX). By aﬃnity
puriﬁcation and mass spectrometry, we identiﬁed RNA polymer-
ase II-associated protein 3 (RPAP3) as a binding protein of
Monad. Overexpression of RPAP3 in HEK 293 potentiated cas-
pase-3 activation and apoptosis induced by TNF-a and CHX. In
addition, knockdown of RPAP3 by RNA interference resulted in
a signiﬁcant reduction of apoptosis induced by TNF-a and CHX
in HEK293 and HeLa cells. These results raise the possibility
that RPAP3, together with Monad, may function as a novel
modulator of apoptosis pathway.
Structured summary:
MINT-6551090:
Monad (uniprotkb:Q96MX6) physically interacts (MI:0218)
with RPAP3 (uniprotkb:Q9H6T3) by anti tag coimmunoprecip-
itation (MI:0007)
MINT-6551101, MINT-6551118:
Monad (uniprotkb:Q96MX6) physically interacts (MI:0218)
with RPAP3 (uniprotkb:Q9H6T3) by pull down (MI:0096)
MINT-6551132:
RPAP3 (uniprotkb:Q9H6T3) physically interacts (MI:0218)
with Monad (uniprotkb:Q96MX6) by anti bait coimmunopre-
cipitation (MI:0006)
 2008 Federation of European Biochemical Societies. Pub-
lished by Elsevier B.V. All rights reserved.
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TNF-a1. Introduction
Apoptosis is an evolutionarily conserved and genetically reg-
ulated biological process that plays a fundamental role in the
development [1,2]. Dysregulation of apoptosis has been linked
to the pathogenesis of a variety of human diseases [3]. Apop-
tosis is mainly orchestrated by a family of aspartate-speciﬁc
cysteine proteases, caspases [4,5]. There are two main path-*Corresponding author. Fax: +81 6 6879 2914.
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doi:10.1016/j.febslet.2008.05.041ways leading to the activation of caspases, the death receptor
pathway and the mitochondrial pathway. The death receptor
pathway is triggered by extracellular ligands, such as FasL
and TRAIL. Binding of the ligands to the death receptor
causes the formation of the death-inducing signaling complex.
This leads to caspase-8 activation and subsequent caspase-3
activation [6]. In the mitochondrial pathway, stress signal from
within the cell induces the release of many proteins, in partic-
ular cytochrome c, from mitochondria into the cytosol. Once
released, cytochrome c stimulates the assembly of an apopto-
some consisting of adapter protein Apaf-1 and procaspase-9
which triggers an activation of caspase-9. Then, caspase-9 acti-
vates caspase-3, cleaving a broad spectrum of proteins in the
cells and leading ultimately to apoptosis [7–10].
In an eﬀort to identify novel molecules involved in apoptosis,
we identiﬁed WD40 repeat protein Monad/WD repeat domain
92 (WDR92) [11]. Overexpression of Monad in HEK293 cells
potentiatedapoptosis and caspase-3 activation inducedby tumor
necrosis factor-a (TNF-a) and cycloheximide (CHX) [11]. Here,
we identify and characterizeMonad-binding protein, FLJ21908,
which has been named RNA polymerase II-associated protein 3
(RPAP3) [12]. RPAP3 contains tetratricopeptide repeat (TPR)
domains. The function of these domains is unknown, but it has
been postulated that they are necessary for protein–protein inter-
actions. It has been also reported thatTPRdomain interactswith
WD40 domain [13]. The TPR motif was ﬁrst identiﬁed as a tan-
demly repeated 34 amino acid sequence in the cell division cycle
genes cdc16, cdc23, and cdc27which encode subunits of the ana-
phase promoting complex [14,15]. In addition to cell cycle regu-
lation, they are involved in processes such as transcriptional
control, protein transport, and protein folding [16,17].
In an attempt to analyze the role of RPAP3 on apoptosis, we
found that knockdown of RPAP3 by RNA interference re-
sulted in a signiﬁcant reduction of apoptosis induced by
TNF-a and CHX, indicating that RPAP3 plays an important
role in apoptosis.2. Materials and methods
2.1. Cloning of RPAP3
Human RPAP3 cDNA, ampliﬁed by PCR using the IMAGE clone
5218249 as a template was cloned into pENTR/D TOPO vector usingblished by Elsevier B.V. All rights reserved.
Fig. 1. Isolation of the Monad complex. (A) Cell extracts from Flp-In
HEK293 cells stably expressing Monad-V5 or CAT-V5 were immu-
noblotted using anti-V5 antibody. (B) Monad interacting proteins were
aﬃnity-puriﬁed from Monad-expressing Flp-In HEH293 cells, sepa-
rated by SDS–PAGE, and stained with Coomassie Brilliant Blue. An
equal amount of extract from CAT-expressing HEK293 cells was
treated identically and used for control. Candidate polypeptides were
excised and subjected to trypsin digestion. The proteins were identiﬁed
by peptide mass ﬁngerprinting. (C) Amino acid sequences of human
RPAP3. The predicted TPR domains are underlined.
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thione S-transferase (GST)-tagged pDEST27 (pDEST27-RPAP3),
using Gateway System according to the manufactures instructions
(Invitrogen, Carlsbad, USA). PCR products were also cloned into
the pcDNA5/FRT/V5-His-TOPO TA cloning vector (pcDNA5-
RPAP3). Sequences were conﬁrmed by automated DNA sequencing.
2.2. Reagents
Recombinant human TNF-a was purchased from R&D systems
(Minneapolis, USA). CHX was from Nacalai tesque (Kyoto, Japan).
Anti-procaspase-3 antibody was from BD Transduction Laboratories
(Lexington, USA). Anti-poly (ADP-ribose) polymerase (PARP) anti-
body and staurosporine were from Calbiochem (La Jolla, USA).
Anti-V5 antibody was from Invitrogen. Anti-glutathione-S-transferase
(GST), anti-Bid and anti-cleaved caspase-8 antibody (18C8) were from
Cell Signaling Technology (Beverly, USA).
2.3. Cell culture
Human embryonic kidney (HEK) 293 cells or HeLa cells were cul-
tured in Dulbeccos modiﬁed Eagles medium supplemented with
10% fetal bovine serum containing 100 lg/ml streptomycin, 100 IU/
ml penicillin and 1 ll/ml amphotericin B.
2.4. Production of antibodies
Rabbit Monad antibodies have been described previously [12]. Rab-
bit RPAP3 antibodies were produced by immunizing rabbits with syn-
thetic peptides corresponding to human RPAP3 [amino acid 57–71].
2.5. Transfection and immunoblotting
HEK293 cells were seeded onto 60-mm Petri dishes and grown for
24 h. The indicated plasmid were transfected with Lipofectamine
2000 according to the manufactures instructions (Invitrogen). After
4 h, transfected cells were returned to growth medium and incubated
for 48 h. Cells were lysed in extraction buﬀer (1% Triton X-100,
120 mM NaCl, 5 mM EDTA, 10% glycerol and 20 mM Tris, pH 7.4)
including protease inhibitor cocktail (Boehringer Mannheim, Mann-
heim, Germany). Total protein was mixed with Laemmli denaturing
buﬀer, separated by SDS–PAGE and transferred to PVDF membranes
(Millipore Corporation, Bedford, USA). Immunoblotting was carried
out as described previously [18].
2.6. Establishment of stable cell line expressing RPAP3
Flp-In 293 cell line expressing V5-tagged RPAP3 was generated as
described previously [11]. In brief, Flp-In 293 cells were transfected
with either pcDNA5/FRT/V5-His-chloramphenicol acetyltransferase
(CAT) or pcDNA5- RPAP3 using Lipofectamine 2000. Hygromycin
(100 lg/ml)-resistant clones were examined for expression of RPAP3
by immunoblotting with anti-V5 antibody.
2.7. Isolation of the Monad complex
Flp-In 293 cells expressing Monad-V5 or CAT-V5 were harvested
and lysed in extraction buﬀer, and the lysate was cleared. The lysate
was incubated with anti-V5 resin (Sigma). After washing, complexes
were eluted with Laemmli denaturing buﬀer and subjected to mass
spectrometry after SDS–PAGE.
2.8. GST pull-down assay
HEK293 cells were transfected with either pcDNA5-Monad (V5-
tagged Monad) or pDEST27- RPAP3 (GST-tagged RPAP3) using
Lipofectamine 2000. After 48 h, cells were harvested and lysed in
extraction buﬀer. The supernatant was incubated with Glutathione Se-
pharose (Amersham Biosciences). The mixture was washed three times
with the buﬀer described above, and eluted with 10 mM glutathione (in
50 mM Tris, pH 8.0). The eluted proteins were boiled in SDS-loading
dye.
2.9. Immunoprecipitation
Equal protein concentrations of HEK293 lysates were incubated
with 3 lg of anti-RPAP3 antibody for 16 h, followed by incubation
with Protein G Sepharose (Amersham Biosciences) for 1 h. The se-
pharose beads were washed ﬁve times with extraction buﬀer, associated
proteins were recovered by boiling for 5 min in Laemmli buﬀer, sepa-rated by SDS–PAGE and subjected to immunoblotting with anti-
Monad antibody.
2.10. Detection of apoptosis
Apoptosis was assayed using cell death detection ELISA (Roche Ap-
plied science, Indianapolis, USA) as described previously [19], accord-
ing to the manufacturers instructions.
2.11. RNA isolation and cDNA synthesis
Total RNA was extracted using TRIzol (Invitrogen), and reverse-
transcribed with SuperScript First-Strand Synthesis System (Invitro-
gen) according to the manufacturers protocol.
2.12. Quantitative real time PCR
TaqMan Gene Expression Assay based quantitative real time PCR
was performed with an ABI PRISM 7900 sequence detection system
(Applied Biosystems, Foster City, USA). Each assay was conducted
in four replicates for each RNA sample. They were assayed with Uni-
versal PCR Master Mix using universal cycling conditions (10 min at
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mer sets for the endogenous control (glyceraldehyde-3-phosphte
dehydrogenase, GAPDH) and target genes were as follows: GAPDH,
Hs99999905_m1; Monad, Hs00399034_m1; RPAP3, Hs00226298_m1.
The cycle threshold number (CT), at which ampliﬁcation entered expo-Fig. 3. Quantitative real time PCR analysis of RPAP3. Relative mRNA
endogenous GAPDH, the amounts of transcripts were compared to those fou
the average values with S.E.M. of triplicates.
Fig. 2. Interaction of RPAP3 with Monad in HEK293 cells. HEK293
cells were transfected with expression vectors encoding RPAP3 and
Monad. Lysates were prepared from transfected cells and were pulled-
down with glutathione beads. Following separation by SDS–PAGE,
immunoblotting was performed using anti-V5 antibody which recog-
nizes the transfected RPAP3 (A) or Monad (B). Results using anti-
GST antibody were also shown. (C) Immunoprecipitation (IP) of
RPAP3 and Monad from HEK293 cells. HEK293 lysate was immu-
noprecipitated with control IgG () or RPAP3 antibody (+).
Following separation by SDS–PAGE, immunoblotting was performed
using anti-Monad antibody.nential phase was used as an indicator of the relative amount of initial
target RNA in each sample. Results are expressed as relative abun-
dance of mRNA normalized to an internal control (GAPDH).
2.13. Knockdown experiments
RPAP3-speciﬁc siRNA was purchased from Qiagen and targeted the
following sequences: 5 0-GGACTATCTTTGAACATAA-30 (RPAP3-
siRNA1); 5 0-GTATTTAAAGCAAATTGAA-3 0 (RPAP3-siRNA2).
AllStars Negative Control siRNA (Qiagen) was used as a control.
2.14. Statistical analysis
Data are expressed as means ± S.E.M. Statistical diﬀerences between
groups were determined using Tukey test after ANOVA.3. Results and discussion
3.1. Identiﬁcation of RPAP3
To identify the proteins that interact with Monad, we have
generated a stable cell line that expresses V5-tagged Monad
(Fig. 1A). Cell extracts were prepared from this line and sub-
jected to aﬃnity puriﬁcation using V5 antibodies. After wash-
ing, binding proteins were eluted from beads and fractionated
by SDS–PAGE. As shown in Fig. 1B, a number of Monad-
associated proteins were observed compared with control sam-
ples. By mass spectrometry, we identiﬁed RPAP3 as a speciﬁc
interactor of Monad. Fig. 1C shows the amino acid sequence
of human RPAP3 (GenBank Accession No. BC056415).
RPAP3 is a protein of 631 amino acids with a deduced molec-
ular mass of 72 kDa and contains tetratricopeptide repeat
(TPR) domains (residues 133–234 and 282–383). TPR domains
consist of three or more TPR motifs, which are highly degen-
erate 34 amino acid repeats. RPAP3 contains six TPR motifs,
forming two TPR domains. The exact function of these repeats
has not been elucidated, but, it is believed that these domains
participate in protein–protein interactions [16,17]. The open
reading frame of human RPAP3 was ampliﬁed by PCR and
cloned into the expression vector with C-terminal V5-tag.
V5-tagged RPAP3 was transiently transfected into HEK293
cells and cell lysates were immunoblotted with anti-V5 anti-
body. RPAP3 was expressed as an approximately 80 kDa pro-
tein (Fig. 4B).expression levels of RPAP3 were shown. After normalizing against
nd in testis, which was arbitrarily deﬁned as 1.0. The results represent
Fig. 4. (A) RPAP3 potentiates apoptosis induced by TNF-a and CHX. Flp-In HEK293 cells stably overexpressing RPAP3 were treated with TNF-a
(10 ng/ml) andCHX (0.5 lg/ml) for 24 h. RelativeDNA fragmentationwas determined by cell death detectionELISA. The results represent the average
values with S.E.M. from three independent experiments. *P < 0.01 compared with vehicle-treated CAT-expressing cells. (B) RPAP3 activates
procaspase-3 and PARP processing induced by TNF-a andCHX. Cell lysates were analyzed by immunoblotting using anti-V5, anti-procaspase-3, anti-
PARP, anti-cleaved caspase-8 or anti-Bid antibody.One of the representative results from three independent experiments is shown. (C)RNAi-mediated
knockdown of RPAP3 in HEK293 cells. Transcriptional level of RPAP3 was determined by real time PCR. The relative expression of RPAP3 was
normalized to GAPDH. Average values of three independent experiments are shown. Bars represent S.E.M. (D) Monad-expressing Flp-In HEK293
cells transfected with control siRNA or RPAP3 siRNA1 were treated with TNF-a (10 ng/ml) and CHX (0.5 lg/ml) for 24 h. Relative DNA
fragmentation was determined bycell deathdetection ELISA. The results represent the average values with S.E.M. from three independent experiments.
#P < 0.01 compared with control-siRNA-treated CAT-expressing cells. *P < 0.01 compared with control-siRNA-treated Monad-expressing cells.
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GST pull-down assay was performed. The HEK293 cells were
transfected with RPAP3 (V5-tagged) in the presence or ab-
sence of Monad (GST-tagged), and the cell lysates were
pulled-down with glutathione beads. Western blot analysis
with anti-V5 antibody following pull-down showed that
RPAP3 interacted with Monad in the cells (Fig. 2A). As shown
in Fig. 2B, we conﬁrmed the result by transfecting with Monad
(V5-tagged) in the presence or absence of RPAP3 (GST-
tagged). We next examined whether RPAP3 and Monad asso-
ciate physiologically. Using HEK293 lysate, we conﬁrmed that
RPAP3 interacted with Monad (Fig. 2C).3.2. Tissue distribution of RPAP3 mRNA
Using quantitative real time PCR, we examined the mRNA
distribution of RPAP3 in various human tissues. The human
RPAP3 transcript was expressed in most tissues examined.
As shown in Fig. 3, RPAP3 transcripts were most abundant
in testis, and also present at lower levels in numerous other tis-
sues including ovary, pancreas, and spleen when we used GAP-
DH as a control. It should be noted that Monad transcripts
were also most abundant in testis, as we reported previously
[11].3.3. Eﬀect of RPAP3 on apoptosis
We generated HEK293 cells stably expressing V5-tagged
RPAP3. To examine apoptosis in the stable cell line,
HEK293 cells were treated with TNF-a and CHX for 24 h.
Apoptosis was assessed using Cell death Detection ELISA.
As shown in Fig. 4A, RPAP3 enhanced apoptosis induced
by TNF-a and CHX. Expression of RPAP3 in stable cell line
was conﬁrmed by immunoblotting with anti-V5 antibody. As
shown in Fig. 4B, the band of RPAP3 disappeared during
the apoptotic process. In addition, RPAP3 induced the activa-
tion of caspase-3, as demonstrated by the processing of procas-
pase-3 and the cleavage of the caspase-3 substrate PARP (Fig.
4B). In the death receptor pathway, pro-apoptotic Bcl-2 family
member Bid needs to be cleaved by caspase-8 and the cleaved
Bid conveys the apoptotic signal to mitochondria [20]. To
determine the molecular basis underlying RPAP3-enhanced
apoptosis, we checked this critical step in TNF-a-induced
apoptosis. As shown in Fig. 4B, cleaved products of caspase-
8 (p41 and p43) and Bid (p15) were observed in RPAP3-over-
expressing lysate. These results indicate that RPAP3 promotes
TNF-a-induced apoptosis through death receptor-mediated
caspase-3 activation pathway.
To test whether endogenous RPAP3 regulates apoptosis, we
knocked down endogenous RPAP3 by small interfering RNA
(siRNA). We generated two unique siRNAs and both resulted
in a four-fold reduction in RPAP3 mRNA in HEK293 cells
(Fig. 4C). We examined the eﬀect of siRNA knockdown of
RPAP3 (RPAP3-siRNA1) on apoptosis in Monad-expressing
HEK293 cells. Treatment with siRNA against RPAP3 resulted
in a signiﬁcant reduction of apoptosis induced by TNF-a and
CHX (Fig. 4D). Similar results were obtained when we used
RPAP3-siRNA2 (data not shown). Protective eﬀect of RPAP3
siRNA was also observed when we treated HeLa cells, with
TNF-a/CHX or staurosporine (Fig. S1). These results suggest
that RPAP3 plays an important role in apoptosis.
TPR domains are composed of loosely conserved 34-amino
acid sequence motifs that are repeated 1–16 times per domain.Originally identiﬁed in components of the anaphase promoting
complex [14,15], TPR domains are now known to mediate spe-
ciﬁc protein interactions in numerous cellular contexts. TPR-
containing proteins include the anaphase promoting complex
(APC) subunits cdc16, cdc23, and cdc27, the NADPH oxidase
subunit p67 phox, hsp90-binding immunophilins, transcription
factors, the PKR protein kinase inhibitor, and peroxisomal
and mitochondrial import proteins [16,17]. We previously re-
ported that Monad has WD40 repeat domain [11]. It has been
reported that TPR domain binds to WD40 domain [13]. Thus,
it is postulated that the TPR domain of RPAP3 acts as a bind-
ing site for Monad.
WD40 repeat domain, which was originally identiﬁed in the
b-subunit of heterotrimeric G-proteins [21] is involved in di-
verse biological functions including signal transduction
[22,23], RNA splicing [24], and transcription [25–29]. It has
been reported that the CUL4-DDB1 ubiquitin E3 ligase asso-
ciates with multiple WD40 repeats proteins and that each
WD40 repeats protein functions as a substrate-speciﬁc adapt-
ors for CUL4-DDB1 ubiquitin E3 ligase [30–33]. Therefore,
Monad or RPAP3 might participate in the event involved in
ubiquitin-proteasome pathway. Identiﬁcation of substrate pro-
tein(s) recruited for ubiquitination by Monad or RPAP3
should clarify the role of Monad and RPAP3 in apoptosis.
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